Literature DB >> 3360222

Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method.

C M Jack, B Sheridan, L Kennedy, R W Stout.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3360222     DOI： 10.1007/bf00395561

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 2.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

3.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

4.  Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control.

Authors:  T J Lyons; J W Baynes; J S Patrick; J A Colwell; M F Lopes-Virella
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122
  4 in total
  9 in total

1.  Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.

Authors:  E Dimitriadis; M Griffin; P Collins; A Johnson; D Owens; G H Tomkin
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

2.  Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus.

Authors:  W Kortlandt; C Benschop; H J van Rijn; D W Erkelens
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

3.  Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis.

Authors:  Kikuo Isoda; Eduardo Folco; M Reza Marwali; Fumitaka Ohsuzu; Peter Libby
Journal:  Atherosclerosis       Date:  2007-12-27       Impact factor: 5.162

4.  Inhibiting low-density lipoprotein glycation ameliorates increased cholesteryl ester synthesis in macrophages and hypercholesterolemia and aortic lipid peroxidation in streptozotocin diabetic rats.

Authors:  Margo P Cohen; Elizabeth A Shea; Van-Yu Wu
Journal:  Metabolism       Date:  2009-11-18       Impact factor: 8.694

5.  Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition.

Authors:  E Dimitriadis; M Griffin; D Owens; A Johnson; P Collins; G H Tomkin
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

6.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

7.  Cellular cholesterol regulation--a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control.

Authors:  D Owens; V Maher; P Collins; A Johnson; G Tomkin
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

Review 8.  Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Authors:  Margo P Cohen; Fuad N Ziyadeh; Sheldon Chen
Journal:  J Lab Clin Med       Date:  2006-05

9.  Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications.

Authors:  Tejaskumar R Kalaria; Habibunnisha B Sirajwala; Mukesh G Gohel
Journal:  J Diabetes Metab Disord       Date:  2016-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.